Skip to main content

Table 9 Comparison of pregnancy outcomes between women with PGDM treated with and without insulin

From: Clinical analysis of 2860 cases of diabetes in pregnancy: a single-center retrospective study

Variable

No. of cases

Insulin group (N = 187)

No-insulin group (N = 153)

χ2 value

P value

Premature delivery

107

49 (26.20%)

58 (37.91%)

5.35

< 0.05

Stillbirth

2

1 (0.53%)

1 (0.65%)

 

1.000a

SGA

76

36 (19.25%)

40 (26.14%)

2.30

0.129

LGA

24

17 (9.09%)

7 (4.58%)

2.62

0.106

Congenital anomalies

35

17 (9.09%)

18 (11.76%)

0.65

0.420

Neonatal asphyxia

37

13 (6.95%)

24 (15.69%)

6.62

< 0.05

NICU transfer

6

2 (1.70%)

4 (2.61%)

 

0.156a

Cesarean section

226

125 (66.84%)

101 (66.01%)

0.03

0.872

Assisted vaginal delivery

6

2 (1.07%)

4 (2.61%)

 

0.415a

PPH

30

12 (6.42%)

18 (11.76%)

2.99

0.084

Puerperal infection

25

11 (5.88%)

14 (9.15%)

1.32

0.251

Maternal ICU transfer

6

2 (1.07%)

4 (2.61%)

 

0.415a

Neonatal hypoglycemia

12

7 (3.74%)

5 (3.27%)

0.06

0.813

Neonatal hyperbilirubinemia

2

0

2 (1.31%)

 

0.202a

  1. PGDM Pregestational diabetes mellitus, SGA Small for gestational age, LGA Large for gestational age, NICU Neonatal intensive care unit, PPH Postpartum hemorrhage, ICU Intensive care unit
  2. aindicates the use of the Fisher exact test